Chase Coleman’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,986,234
Closed -$133M 77
2022
Q2
$133M Sell
16,986,234
-687,000
-4% -$5.9M 1.12% 23
2022
Q1
$196M Buy
17,673,234
+3,880,134
+28% +$43.5M 0.74% 28
2021
Q4
$242M Buy
13,793,100
+3,060,217
+29% +$59.4M 0.53% 40
2021
Q3
$217M Buy
10,732,883
+3,112,883
+41% +$80M 0.42% 45
2021
Q2
$252M Hold
7,620,000
0.47% 39
2021
Q1
$298M Buy
7,620,000
+3,690,000
+94% +$173M 0.69% 35
2020
Q4
$172M Buy
+3,930,000
New +$134M 0.44% 37

Other funds holding ONEM

Chase Coleman's ONEM Position: Q3 2022 in Review

Chase Coleman sold out of 1Life Healthcare (ONEM) in Q3 2022, closing a stake of 16,986,234 shares — an estimated $133M sold.

Chase Coleman first reported a position in ONEM in Q4 2020 and held it in 7 quarters. The position peaked at $298M in Q1 2021. 222 funds tracked by Wall St. Rank hold ONEM as of Q3 2022.

  • Chase Coleman reported no remaining 1Life Healthcare position as of Q3 2022 after selling out during the quarter.
  • Chase Coleman sold 16,986,234 1Life Healthcare shares in Q3 2022, an estimated $133M.
  • Chase Coleman first reported a position in 1Life Healthcare in Q4 2020 and held it in 7 quarters.
  • Chase Coleman's 1Life Healthcare position peaked at $298M in Q1 2021.
  • 222 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2022.

Based on Tiger Global Management's 13F filing for Q3 2022, filed 14 Nov 2022.